One in eight U.S. adults reported taking a GLP-1 for weight loss, diabetes or another condition. For pharmacy and benefits leaders, that raises a question beyond access: How can that investment support lasting outcomes?
The coverage question is largely settled. The harder one is what those dollars buy. Real-world data tells an uncomfortable story. Only 8% of people who start a GLP-1 for weight loss are still on it at three years and most regain the weight once they stop.
This guide provides pharmacy and benefits leaders with a practical blueprint to strengthen their GLP-1 strategy. Learn how to pair medication with provider-led nutrition coaching—and create a safe off-ramp for deprescribing when appropriate.
You’ll learn:
- Where GLP-1 strategies can fall short after treatment begins
- How utilization management can support long-term treatment goals
- Three ways to improve the value of GLP-1 spending and support lasting outcomes